Atossa Genetics, Inc.

4105 E Madison St, Suite 320
Seattle, WA 98122 USA
Click for website

Research Sector Medical Devices; Diagnostics

Summary Description Developed novel cellular and molecular diagnostics and treatments for early breast cancer.

Management Dr. Steven C. Quay, Chairman of the Board and CEO; Dr. Shu-Chih Chen, Chief Scientific Officer and Director; John Barnhart, Director

Click here for Financial Data
Keywords: breast cancer, oncology, womens' health,


Updated: Mar. 17, 2018


With US distribution agreements with top healthcare companies, Atossa Genetics offers proprietary medical devices and laboratory services in women's health and is looking to develop their presence in ......view more

Products / Services

FullCYTE, ArgusCYTE CTC Test, NextCYTE Lymph Node Predictor Test, ForeCYTE Breast Aspirator......view more

Technology / Differentiation

The MASCT System is FDA cleared for the collection of nipple aspirate fluid for cytological evaluation. The collected fluid can be used in the determination and/or differentiation of normal versus pre...view more

Market / Customers

Women......view more